Units Sold by Quarter Units Sold by Quarter Quarterly Customer Sales / Quarterly ASC Sales Quarterly Customer Sales / Quarterly…
NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline…
Significant progress achieved in 2021: Pipeline now includes six internally discovered small molecule compounds targeting clinically validated pathways in cancers…
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce an…
Successful Execution and Completion of Enrollment in Four Late-Stage Clinical Trials Across Nyxol and APX3330 Programs in First Quarter of…
KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement CELEBRATION, Fla., March 16,…
ADUHELM continued to reduce two key Alzheimer’s disease pathologies, amyloid beta plaques and p-tau181, in patients treated for up to…
HOOPP President & CEO Jeff Wendling HOOPP President & CEO Jeff WendlingTORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- The Healthcare…
Prof. Casper H.J. van Eijck, MD, PhD Prof. Casper H.J. van Eijck, MD, PhDData seen to date indicates that Ampligen®…
New York, New York--(Newsfile Corp. - March 16, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today…